Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.59−0.08 (-11.39%)
Close on Nov 20, 2026Market cap $54.83MP/E –Yield –
Anavex Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Anavex Life Sciences
Anavex Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?